Approval · Notice of Compliance 15126 · 2014
INFLECTRA: Notice of Compliance 15126
Issued January 15, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15126
- Date
- January 15, 2014
- Company
- Celltrion Healthcare Co Ltd
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFLECTRA | 02419475 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL